Lung cancer
Conditions
Interventions
Sponsors
Shanghai Pulmonary Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. The subjects should be aged 18-75 years old when they signed the informed consent form, both male and female; 2. Histologically or cytologically confirmed non-small cell lung cancer (NSCLC) and stage IIIB-IV tumor; 3. Provide relevant documents of the subject's EGFR mutation and ALK translocation status, which must be negative; 4. Must receive anti-PD1/PD-L1 immune monotherapy or immune combination chemotherapy; 5. According to RECIST 1.1 criteria, subjects must have measurable target lesions by CT or MRI; 6. Perform all screening laboratory tests as required by the protocol and within 14 days of the first dose. The values of laboratory tests done for screening must meet the criteria; 7. With my consent and signed informed consent, willing and able to comply with the planned visits, study treatments, laboratory tests and other experimental procedures.
Exclusion criteria
Exclusion criteria: No.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ACC, SEN, SPE, AUC of ROC; | — |
Countries
China
Contacts
Public ContactWu Fengying
Shanghai Pulmonary Hospital
Outcome results
None listed